Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Syros Pharmaceuticals, Inc. | Director | Common Stock | 33.2K | $164K | $4.95 | Jun 5, 2024 | Direct |
Syros Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 6K | Jun 5, 2024 | Direct | ||
TYME TECHNOLOGIES, INC. | Director | Common Stock | 0 | $0.24 | Sep 16, 2022 | Direct | |
TYME TECHNOLOGIES, INC. | Director | Director Stock Option - Option to buy | 0 | Sep 16, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SYRS | Syros Pharmaceuticals, Inc. | Jun 5, 2024 | 2 | $0 | 4 | Jun 7, 2024 | Director |
SYRS | Syros Pharmaceuticals, Inc. | Jun 1, 2023 | 2 | $0 | 4 | Jun 2, 2023 | Director |
SYRS | Syros Pharmaceuticals, Inc. | Sep 29, 2022 | 2 | $106K | 4 | Oct 3, 2022 | Director |
SYRS | Syros Pharmaceuticals, Inc. | Sep 16, 2022 | 11 | $0 | 4/A | Apr 20, 2023 | Director |
SYRS | Syros Pharmaceuticals, Inc. | Sep 16, 2022 | 0 | $0 | 3 | Sep 19, 2022 | Director |
TYME | TYME TECHNOLOGIES, INC. | Sep 16, 2022 | 9 | $0 | 4 | Sep 16, 2022 | Director |
TYME | TYME TECHNOLOGIES, INC. | Aug 24, 2022 | 1 | $0 | 4 | Aug 29, 2022 | Director |
TYME | TYME TECHNOLOGIES, INC. | Aug 24, 2021 | 1 | $0 | 4 | Aug 26, 2021 | Director |